Healthcare ❯Vaccine Development ❯mRNA Technology ❯Vaccine Efficacy

KP.2 and JN.1 Variants

FDA Approves Updated COVID-19 Vaccines Targeting New Variants

New vaccines from Pfizer and Moderna aim to enhance protection as cases rise; availability begins in September.